Company Valuation: MedCap AB

Data adjusted to current consolidation scope
Fiscal Period: December 2023 2024 2025 2026 2027 2028
Market Cap 1 4,997 8,899 8,278 8,192 - -
Change - 78.07% -6.99% -1.04% - -
Enterprise Value (EV) 1 4,997 9,176 8,359 8,361 8,141 7,921
Change - 83.61% -8.9% 0.02% -2.63% -2.7%
P/E 29.1x 42.9x - 29x 26.9x 23.9x
PBR - 6.95x - 4.6x 3.92x 3.37x
PEG - 2.1x - - 3.53x 1.9x
Capitalization / Revenue - 4.93x 3.93x 3.45x 3.13x 2.87x
EV / Revenue - 5.08x 3.97x 3.52x 3.11x 2.78x
EV / EBITDA - 23.7x 18.3x 14x 13.6x 12x
EV / EBIT - 33.7x 27.6x 20.2x 19.8x 17.7x
EV / FCF - 28.8x 26.4x 39.9x 23.9x 20.3x
FCF Yield - 3.47% 3.79% 2.51% 4.19% 4.94%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 11.6 14 - 18.88 20.32 22.91
Distribution rate - - - - - -
Net sales 1 - 1,807 2,108 2,376 2,616 2,850
EBITDA 1 - 387.7 456.3 598 599.5 657.5
EBIT 1 - 272.3 302.9 413.5 410.5 448.5
Net income 1 172.2 207.4 219.8 282 296.5 330
Net Debt 1 - 276.5 81.3 169 -51 -271
Reference price 2 337.50 601.00 549.00 547.00 547.00 547.00
Nbr of stocks (in thousands) 14,807 14,807 15,078 14,976 - -
Announcement Date 31/1/24 31/1/25 5/2/26 - - -
1SEK in Million2SEK
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- 3.59x14.27x - 829M
22.75x6.2x13.4x1.91% 185B
14.25x3.39x - 2.52% 146B
16.25x7.37x - 1.52% 102B
19.65x7.01x12.49x4.34% 93.58B
19.07x11.31x16.83x0.82% 85.17B
20.69x12.96x22.5x3.95% 81.32B
15.06x11.24x8.75x1.86% 70.84B
12.65x4.83x - 2.06% 46.26B
Average 17.54x 7.54x 14.71x 2.37% 90B
Weighted average by Cap. 18.20x 7.51x 14.60x 2.35%

Y-o-Y evolution of P/E

Valuation ratios - P/E - MedCap AB

Historical PBR trend

Valuation ratios - PBR - MedCap AB

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - MedCap AB

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - MedCap AB